Reprise Biomedical
MN - PlymouthMedical Devices
Focus: Reprise Biomedical is a medical device company founded in 2024, headquartered in Plymouth, MN, specializing in biological wound care devices manufactured using proprietary perfusion decellularization technology. The company is publicly listed but appears to be in early commercialization stage with a focused wound care portfolio.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Reprise Biomedical
AI assessmentNot HiringNo open roles listed right now. Follow Reprise Biomedical to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Reprise Biomedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Acellular Porcine-Derived Wound Matrix
Diabetic Foot Ulcers (DFUs)Clinical Trials (1)
NCT06939673Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
N/AHelp build intelligence for Reprise Biomedical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.